Sunday, March 22, 2026

 

Why some people naturally control HIV even after stopping therapy — and how we can leverage that to treat others



New research offers a path toward life without daily HIV pills, suggesting common diabetes pill could help achieve long-term remission.




Gladstone Institutes

Scientists at Gladstone Institutes 

image: 

A team of Gladstone scientists—including Ashley George (left) and Nadia Roan (right)—uncovered a new path toward life without daily HIV pills, suggesting that a common diabetes pill could help achieve long-term remission.

view more 

Credit: Michael Short/Gladstone Institutes




SAN FRANCISCO—For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes back within weeks.

But not for everyone; scientists have been baffled by rare individuals who, after stopping the drug regimen, keep the virus under control for months or even years.

“Strikingly, a small number of people rebound much more slowly and take multiple months or even longer to rebound,” says Nadia Roan, PhD, senior investigator at Gladstone Institutes.

In a study published in the journal Immunity, Roan and her team begin to reveal why that is—and in doing so, uncover possible new paths toward long-term health for people living with HIV without the need for antiretroviral therapy.

Among their key findings, the team discovered two specific genes inside infected cells that act like security locks to keep the virus asleep. And perhaps most significantly, they also found that a common diabetes drug, metformin, can activate one of these locks to keep the virus in its dormant state.

“Our data suggest metformin might be able to delay, or possibly even prevent HIV rebound in some individuals, which is exciting because it’s a very safe and affordable drug,” says Roan, senior author on the study. “We are now very interested in pushing forward with pre-clinical and eventually clinical studies to directly test these potential benefits.”

Working Toward a Functional Cure

In people with HIV, antiretroviral therapy successfully controls the virus, but “reservoirs” of immune cells containing a permanent copy of HIV’s genetic code persist. If treatment is disrupted, this genetic code typically begins to generate active HIV, leading to a return of symptoms and, if left untreated, to acquired immunodeficiency syndrome (AIDS).

By studying the rare individuals who continue to suppress the virus even after treatment ends, Roan and her team sought to pinpoint features of immune cells that can keep the virus locked down.

They turned to four recently completed clinical trials in which people with HIV deliberately went off treatment—in some cases to test potential HIV cures—and were carefully monitored for HIV rebound, at which time the individuals restarted antiretroviral therapy.

Roan’s group obtained blood specimens taken from 75 trial participants immediately before they paused therapy, and measured levels of genes and proteins within multiple types of immune cells from the samples to uncover associations between these features and how long it took for HIV to rebound.

These efforts yielded several important discoveries. In two of the trials, delayed rebound was associated with higher levels of a specific type of immune cell known as stem cell memory CD8+ T cells. In fact, the two patients with the most extremely delayed rebound—more than 22 weeks for one and over 33 for the other—also had the highest levels of these cells.

“These CD8+ T cells appear to have ‘stem-like’ features and might be able to stick around to continue replenishing themselves for prolonged periods of time, which may help them contribute to long periods of ART-free HIV control”, Roan says.

In another trial, people with an atypical type of natural killer cells rebounded later than patients with the conventional version. Natural killer cells are a type of immune cell typically thought of as destroyers of virus-infected cells. But they can also help regulate how other immune cells operate, which may impact post-therapy HIV rebound.

“All together, our findings suggest there’s probably not just one solution for suppressing HIV,” says Ashley George, PhD, research scientist at Gladstone and co-first author on the study. “By leveraging different features of immune cells that can help fight infection, we likely have multiple opportunities to control HIV without the need for ART.”

Trial-Ready Results for Metformin

The study’s most striking findings came from some of the patients’ CD4+ T cells—the main cell type that serves as a reservoir for HIV.

People whose reservoir cells had higher levels of two particular genes, DDIT4 and ZNF254, tended to have longer HIV rebound times after stopping antiretroviral therapy. In follow-up lab experiments, Roan and her team confirmed that both genes can suppress HIV.

“Both genes represent possible new targets for a promising ‘block and lock’ strategy for curing HIV, in which drugs would first be used to block HIV activation, followed by ways to make this block permanent,” George says.

This approach is a major focus of the HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory, a multidisciplinary group of researchers, including Roan and other co-authors on the new study, working toward an HIV cure.

When they further analyzed publicly available data, the team uncovered more supporting evidence. They found that people with higher levels of the two genes had reduced HIV activity in their cells. And, in “elite controllers”— people whose bodies naturally suppress HIV from the start of infection, even without therapy— levels of the gene ZNF254 among CD4+ T cells are much higher.

“One possibility we’re imagining for the future is that we could somehow deliver ZNF254 to infected cells in order to turn people into elite controllers,” George says. “We could also try to engineer an even stronger version of this gene.”

But of all findings in the new study, the link between gene DDIT4 and delayed rebound may have the most immediate ramifications for patients. That’s because levels of this gene can be boosted by the drug metformin—something that had already been observed by the scientific community in non-immune cells, and which this study demonstrated is also true in T cells.

This led the scientists to conduct a series of experiments to validate whether metformin can help suppress HIV. In one notable experiment, treating cells taken from people with HIV with metformin blocked the ability of HIV to reactivate, suggesting a possible role for this drug in helping achieve “block and lock”.

The team is next planning to test metformin and related compounds in a variety of pre-clinical models for their ability to prevent HIV reservoir cells from generating active HIV upon interruption of antiretroviral treatment.

Drugs that effectively silence HIV could also have health benefits even for those who stay on antiretroviral therapy. This is because the drugs can limit the levels of viral gene products—a driver of inflammation—that these individuals are chronically exposed to.

“We are excited to pursue HIV silencing strategies both as a way to achieve block and lock, but also as a strategy to improve the overall health of people with HIV by lessening chronic inflammation,” Roan says.

###

About the Study

The paper, “Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound,” was published by the journal Immunity on March 13, 2026.

The authors are Tongcui Ma, Ashley George, Zichong Li, Reuben Thomas, Kailin Yin, Min-Gyoung Shin, Mauricio Montano, Yusuke Matsui, Kyrlia Young, Julia Prigann, Julie Frouard, Katie Pollard, Melanie Ott, Warner Greene, and Nadia Roan of Gladstone; Ashokkumar Manickam, Edward Browne, and Nancie Archin of University of North Carolina at Chapel Hill; Sabrina Leddy and Cedric Feschotte of Cornell University; Maisha Adiba, Christina Herrde, and Ulrike Lange of Leibniz Institute of Virology; Douglas Nixon of Feinstein Institutes for Medical Research; Jonathan Li of Brigham and Women's Hospital; David Smith of UC San Diego; Steven Deeks, Sulggi Lee, and Satish K. Pillai of UC San Francisco; Ole S. Søgaard and Martin Tolstrupof Aarhus University; Mohamed Abdel-Mohsen of Northwestern University; and Robert Siliciano of Johns Hopkins University School of Medicine.

The work was supported by the James B. Pendleton Charitable Trust, the National Institutes of Health (R01-AI183286, R01-DK131526, R01-AI147777, R01-AG092241, P01-AI169606, P01-AI131374, P01-AI169768, R21-AI172060, UM1-AI164559, UM1-AI164567, UM1-AI068636, UM1-AI068634, UM1-AI106701, S10-RR028962, P30-AI027763, P30-DK063720, and S10-OD018040), and the Gates Foundation (NV-033977).

About Gladstone Institutes

Gladstone Institutes is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. Established in 1979, it is located in the epicenter of biomedical and technological innovation, in the Mission Bay neighborhood of San Francisco. Gladstone has created a research model that disrupts how science is done, funds big ideas, and attracts the brightest minds.

“Unleash the West of England to power up UK growth” - The Brunel Centre publishes Economic Audit



The Brunel Centre, a new research and insight hub, releases Strategic Economic Audit of the West of England, finding the region is England’s most productive Combined Authority area outside London



University of Bath





  • The Brunel Centre, a new research and insight hub, releases Strategic Economic Audit of the West of England   
  • The region is England’s most productive Combined Authority area outside London   

  • The West of England has a highly educated and skilled workforce, globally competitive universities and leading industrial clusters   

  • Despite these strengths, there are challenges: investment, transport, housing affordability and inequality   

  • The Economic Audit will be launched at the Festival of Flourishing Regions in Bristol today, Thursday 19 March   

  • The Brunel Centre’s Data Hub and Observatory also launches today, making the data underpinning the audit and other insights publicly accessible   

The Brunel Centre, a new data and research centre designed to support sustainable and inclusive growth and industrial strategy in the West of England, today releases its first major publication, a Strategic Economic Audit of the region. 

Its headline finding shows that the region possesses exceptional potential and is one of the UK’s most dynamic regional economies but is limited by structural constraints. 

The West of England became the most productive Combined Authority area in England outside London in 2023. Its post-pandemic recovery has also been markedly stronger than the UK average. 

Compiled by researchers at the University of Bath, the University of the West of England (UWE Bristol) and Futures West, the Economic Audit covers Bristol, Bath & North East Somerset, South Gloucestershire, and North Somerset. 

It draws on official data from the Office for National Statistics and other sources, supplemented with primary qualitative research including interviews with local business leaders. 

Launching the report at the Festival of Flourishing Regions in Bristol today, Dr Lucy Martin, Director of the Brunel Centre, will say: “The evidence is unequivocal: the West of England is one of the UK’s most dynamic regional economies, with growth significantly exceeding the national average since 2008.  

“But the conditions underpinning that success are under strain – addressing these pressures with coordinated, long-term action is essential. Unleashing the West of England could see the region reach its potential and power the UK’s growth.” 

Collective action needed to build sustainable growth – key findings 

The Economic Audit’s key recommendation calls for the region to work collectively across the public, private and voluntary sectors to focus on productivity‑led growth, facilitate stronger pathways into employment, take region‑wide action on housing, transport, skills and inequalities, and accelerate the net zero transition. 

By addressing these constraints, the researchers say the West of England can translate its strong economic fundamentals into a more inclusive, resilient and sustainable model of long‑term growth for the region and the UK. 

Other key findings include: 

  • Export strength: the region generates exports worth £9.5 billion and runs a trade surplus, in contrast to the UK overall 

  • The region is home to world-leading innovation clusters, as well as strong knowledge-intensive, digital and creative industries 

  • A strong but place-specific labour market: The cities of Bristol and Bath are magnets for skilled workers, students and young professionals. Nearly half of residents have degree-level qualifications, one of the highest rates in England 

  • Surrounding areas experience higher underemployment and struggle to retain skilled professionals in specific sectors  

  • Transport is a ‘defining challenge’: congestion in the cities ranks among the worst in the UK, with unreliable, slow and poorly integrated public transport 

  • Housing and digital access issues: Housing affordability and shortages and inconsistent digital access are directly limiting growth and inclusion 

  • Localised pressures from child poverty to youth mental health demand are increasing, leading to untapped potential across the region 

  • Climate and environmental pressures: transport dominates overall greenhouse gas emissions, delivery of domestic retrofits to decarbonise homes is below target, and ecological decline threatens long-term resilience 

Dr Lucy Martin adds: “We are proud to be adding a strong new economic capability to the West of England today by releasing our first Strategic Economic Audit and launching our Data Hub and Observatory. 

“Our research gives the clearest picture yet of West of England’s economy: this is a great place to live and work, with a strong-performing economy. The fact we’ve had recent successes, while pockets of deprivation remain, make the West of England a natural place to explore how growth can power social mobility.” 

Andrea Dell, Director of Futures West at Business West, says: “This is an important stocktake of the region. We know this is the level of insight that policymakers and businesses need to justify their decision to invest. Investment in the West of England will yield strong returns, not just for the region, but also for the wider UK. Money invested here will help drive national growth and innovation. 

“It is also clear that our regional stakeholders must work together to address these issues, as no single organisation can do this alone. Over the past year we have seen real momentum build in promoting the West of England, including the launch of the West of England Growth Strategy. I’m excited by what our region can achieve by using this evidence to strengthen the case to invest here, driving economic growth and improved living standards.”  

Dr Damian Whittard, Associate Professor of Economics at UWE Bristol, says: “The Strategic Economic Audit shows that the West of England is a strong and vibrant region with enormous potential. Our research highlights the need for inclusive and sustainable economic growth within the region that supports the transition to net zero. Tackling inequality and spatial disparities, improving transport and connectivity, and delivering shared prosperity across communities is central to unlocking the region’s potential.” 

Helen Godwin, Mayor of the West of England, says: “As we continue working together to deliver our ambitious Growth Strategy, reinforced by the Brunel Centre’s Strategic Economic Audit, the West of England is well-placed to secure greater investment to improve transport, build homes, and create new jobs. It is also wonderful to see the Festival of Flourishing Regions once again taking place today here in the country’s fastest growing regional economy – which is also the most productive outside of the capital.” 

New online Data Hub and Observatory launch alongside audit 

Alongside the launch of the Strategic Economic Audit today, the Brunel Centre will also unveil its online Data Hub and Observatory. 

The observatory is an online and real-time data resource on the economic performance of the region. Hosting a range of data, it makes available the evidence that underpins today’s Audit and the ongoing work of the Centre freely available to businesses, policymakers and the public. 

The Data Observatory is located at https://www.thebrunelcentre.co.uk/   

Festival of Flourishing Regions 

The launch will take place at the Festival of Flourishing Regions at the Watershed in Bristol today (Thursday 19 March). 

Jointly hosted by the Brunel Centre and Futures West, the event will feature discussions on devolution, investment and growth, with contributions from local and national business and political leaders. 

About the Brunel Centre 

The Brunel Centre was launched in 2025 by the University of Bath, the University of the West of England (UWE Bristol) and Futures West, backed by £4.5 million in funding from Research England. 

It published a policy insight report, Closing the Productivity Gap, in September 2025. 

In the coming months, the Brunel Centre will publish further economic insights, as well as hosting events and workshops designed to enable collaborations that facilitate inclusive and sustainable economic growth. The Centre will also open a consultancy service to businesses and key decision makers in the region and nationally.  

 

ENDS 

The Festival of Flourishing Regions is taking place at Watershed, Canon Rd, Bristol, BS1 5TX on Thursday 19 March from 8:45am to 5:30pm. You can register for tickets and see the agenda at: https://tinyurl.com/2s4yvkp8  

The Brunel Centre website and Data Hub and Observatory will be live from Thursday 19 March: https://www.thebrunelcentre.co.uk/   

For more information or to request interviews, contact: 

Will McManus, University of Bath: wem25@bath.ac.uk / +44(0)1225 385 798 

Bethan Jones, UWE Bristol: bethan17.jones@uwe.ac.uk / +44(0) 117 328 1906 

Amy Drummond, Futures West: Amy.Drummond@BusinessWest.co.uk / +44 7586 746039 

About the University of Bath 

The University of Bath is one of the UK's leading universities, recognised for high-impact research, excellence in education, an outstanding student experience and strong graduate prospects. 

  • We are ranked among the top 10% of universities globally, placing 132nd in the QS World University Rankings 2026. 

  • We are ranked in the top 10 in all of the UK’s major university guides. 

  • The University achieved a triple Gold award in the last Teaching Excellence Framework 2023, the highest awards possible, for both the overall assessment and for student outcomes and student experience. The Teaching Excellence Framework (TEF) is a national scheme run by the Office for Students (OfS). 

  • We are The Times and The Sunday Times Sport University of the Year 2026. 

Research at Bath is shaping a better future through innovation in sustainability, health, and digital technologies. Find out all about our Research with Impact: http://bit.ly/3ISz1Wu 

 

About Futures West 

Futures West, initiated by Business West, is a collaboration between businesses and leading universities to drive long-term change for the benefit of the wider West of England Region. In partnership with the Brunel Centre, Futures West will promote evidence-based insights to attract investors and inform policy makers. 

https://www.linkedin.com/company/futures-west-foundation 

The University of the West of England (UWE Bristol) 

The University of the West of England (UWE Bristol) has a global and inclusive outlook, with approximately 38,000 students and strong industry networks and connections with over 1,000 employers. 

RISE – standing for Research, Innovation, Skills and Enterprise – is UWE Bristol’s institutional framework which shapes its purpose, culture and future growth. It brings together research focusing on real world challenges, innovation that positively impacts people and the planet, collaboration with industry to teach skills for the future jobs market, and supports a thriving enterprise environment at UWE Bristol’s University Enterprise Zone. 

UWE Bristol plays a pivotal role in the region contributing £500 million to the regional economy annually. With over £400 million invested in infrastructure, buildings and facilities across all campuses in the past 10 years, UWE Bristol is creating a place for learning that is innovative, ambitious, connected, enabling and inclusive. 

UWE Bristol is ranked 38th in the UK in the Guardian University Guide 2026. The University is rated ‘1st Class’ for sustainability, ranked 14th out of 149 higher education institutions in People & Planet’s latest sustainability league table. www.uwe.ac.uk 

 

More sleep and physical activity may prevent Type 2 diabetes in teens



American Heart Association EPI|Lifestyle Scientific Sessions 2026 – Oral Abstract 71




American Heart Association





Research Highlights:

  • If adolescents replaced 30 minutes of sedentary time each day with sleep or moderate-to-vigorous physical activity, it may reduce their insulin resistance and thus reduce their risk of developing Type 2 diabetes, according to an analysis of health data from Project Viva, a long-term study of the health of women and children in Eastern Massachusetts.
  • Substituting 30 minutes per day of sedentary time with moderate-to-vigorous physical activity reduced a measurement of insulin resistance by nearly 15%.
  • Public health initiatives to promote physical activity or sleep rather than sedentary activities could help preserve cardiometabolic health among teens in the U.S.
  • Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

Embargoed until 1:30 p.m. ET/12:30 p.m. CT, Friday, March 20, 2026

Boston, March 20, 2026 — Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17-20, 2026, and offers the latest epidemiological science on prevention, lifestyle and cardiometabolic health.

“I was happily surprised with the strength of the association of replacing 30 minutes of sedentary time with moderate-to-vigorous physical activity—a 15% lower insulin resistance is quite a big change,” said Soren Harnois-Leblanc, Ph.D., R.D., lead author of the study and a postdoctoral researcher in the department of population medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School, both in Boston. “Our findings mean that switching from sedentary behaviors to moderate-to-vigorous physical activity or sleep, even if it is only a few minutes per day to start, was beneficial for health.”

To assess the impact of typical daily activities on the development of insulin resistance in teenagers, investigators examined health data from Project Viva, an ongoing health study of children born between 1999-2002 and their mothers. Insulin resistance was measured using Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), a test that estimates insulin resistance based on fasting blood glucose and insulin levels. In early adolescence, at an average of nearly 13 years old, 802 participants kept sleep logs and wore an accelerometer (a sensor that quantifies movement accelerations, from which researchers can derive the intensity and duration of physical activity) constantly for 7-10 days, providing a breakdown of the movement activities they engaged in over a typical 24 hours.

By far, the highest percentage of daily time, 48% or 11.5 hours per day, was spent in sedentary activities. Examples of sedentary time may include sitting in class, doing homework, commuting and downtime in the evening, which often comes with screen time on an electronic device or watching TV.

Other daily activities, reported over a 24-hour period, included sleep (33%), low-intensity physical activity (such as casual walking, 17%), and moderate-vigorous physical activity (such as running, swimming or playing basketball, 2%).

The researchers then calculated how much a shift of just 30 minutes from sedentary activity to various types of physical activity or sleep could have impacted estimated insulin resistance levels in 394 of the study participants.

Among the study findings:

  • Adolescents who replaced 30 minutes of sedentary time with moderate-vigorous physical activity could lower a measurement of insulin resistance, or lowering their HOMA IR score, by nearly 15%;
  • Participants who exchanged 30 minutes of sedentary time with sleep could lower insulin resistance by nearly 5%;
  • Shifting 30 minutes of sedentary time to low-intensity physical activity did not have a significant change in insulin resistance levels.
  • While activity composition was associated with insulin resistance, it was not associated with levels of adiponectin (a hormone produced by fat cells) or fasting glucose levels (a measure used to diagnose prediabetes and Type 2 diabetes).

“This study shows that young adolescents spend a lot of their day being sedentary and only a small amount of time being physically active,” said Kershaw Patel, M.D., an American Heart Association volunteer and chair elect of the Association’s Council on Epidemiology and Prevention. “Interestingly, teens who had more moderate to vigorous physical activity early in adolescence showed signs of lower insulin resistance later on. The big takeaway is being active early in life can really make a difference for long‑term health.” Patel, who was not involved in this study, is an assistant professor of cardiology at Houston Methodist Hospital’s DeBakey Heart & Vascular Institute in Houston.

The American Heart Association’s Life’s Essential 8 metrics for optimal cardiovascular health includes strategies for incorporating healthy lifestyle into daily life. For example, dimming lights before bedtime, creating a nighttime routine that doesn’t include electronic devices with screens and putting the phone on “do not disturb” (or leaving it outside the bedroom while sleeping) can help to improve quality and quantity of sleep. Integrating physical activities with social time with friends, to clear your mind or reduce stress can make hikes or other exercise more appealing than sedentary activities.

While the study did not find an association between more time spent in light physical activity and lower insulin resistance, the investigators urge additional research on this topic.                                  

“More time spent in light physical activity may be beneficial to prevent cardiometabolic disease in adults. Light physical activity is an interesting target because it is likely easier to integrate into everyday routines,” said Harnois-Leblanc.

The current study had some limitations, including that insulin resistance information in late adolescence was available for only 49% of participants who had accelerometer data collected in early adolescence. Additionally, cause-and-effect for daily activities and insulin resistance cannot be proven by this data analysis.

Study details, background and design:

  • The study included health information for 802 participants, ages 12-17, who were born between 1999-2002 in Eastern Massachusetts, and who were enrolled in Project Viva, an ongoing study aimed at improving the health of children and their mothers.
  • 52% of participants were female, 64% were self-identified as non-Hispanic white, 15% self-identified as non-Hispanic Black and 9% self-identified as Hispanic.
  • Participants in early adolescence (median age of 12.9 years) wore a wrist accelerometer for 7-10 consecutive days and completed sleep logs, allowing researchers to calculate the average number of minutes in each 24-hour period were spent sleeping vs. sedentary time vs. light physical activity vs. moderate to vigorous physical activity.
  • In late adolescence (median age of 17.5 years), 394 participants with accelerometer data had fasting blood level tests collected to measure levels of adiponectin (a hormone produced by fat cells), glucose (sugar) and insulin. Fasting glucose and fasting insulin levels were used to calculate HOMA-IR, a measure of insulin resistance that informs on the risk of progressing to Type 2 diabetes.
  • Investigators used a statistical method called compositional data analysis to examine the distribution of 4 types of physical activities within a 24-hour period. They then used modeling to estimate how 30-minute substitutions from one behavior to another could affect test results in later adolescence. Results were adjusted for age, sex, the season in which the participants wore the accelerometer, mother’s educational level and family income.

Co-authors, disclosures and funding sources are listed in the abstract. 

Statements and conclusions of studies that are presented at the American Heart Association/American Stroke Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

The American Heart Association’s EPI|LIFESTYLE Scientific Sessions is the world’s premier meeting dedicated to the latest advances in population-based science. The meeting is Tuesday-Friday, March 17-20, 2026, in Boston. The primary goal of the meeting is to promote the development and application of translational and population science to prevent heart disease and stroke and foster cardiovascular health. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health and prevention-oriented clinical trials. The Councils on Epidemiology and Prevention and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI|Lifestyle Scientific Sessions 2026. Follow the conference on X at #EPILifestyle26.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

###